05_payamS31A5349 Intro_GeneralUpdate_15NOV2017 INTERTB v. 2 COPYRIGHT AMENDED.pdf (1.21 MB)
Tuberculosis Trials Consortium Study 31
presentation
posted on 2018-02-05, 16:32 authored by Payam NahidTuberculosis Trials Consortium Study 31
Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial - Payam Nahid
This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting are available from the link below.
Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial - Payam Nahid
This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting are available from the link below.
History
Research Institute
- Infection and Immunity
Value
- normal
AccessType
- open